INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
KS

Kiss Szilard

DirectorCIK 0002026299

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells0 / 0
Max Insider Score9
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
21.0K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Adverum Biotechnologies, Inc.Director · Dec 10, 2025
9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D
—
1,250 sh
Dec 9, 2025
Dec 10, 2025
traded Dec 9, 2025
+1d
SEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
8,000 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
4,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
2,500 sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence

9
KS
Kiss SzilardDirector
ADVMAdverum Biotechnologies, Inc.
Disposition to issuer
D—
10.4K sh
Dec 9, 2025Dec 10, 2025
traded Dec 9, 2025
+1dSEC FORM 4

Evidence